– Topline results from Phase 2a study – Nearly 60% of all patients treated with gemlapodect and 88% of patients…
Mr. Korenberg is a seasoned executive with significant operational and financial leadership experience, including senior roles at Ligand Pharmaceuticals (NASDAQ:…
TORONTO, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading…
STOCKHOLM, SE / ACCESSWIRE / October 17, 2024 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR),…
NEW YORK, Oct. 16, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape- The global telerehabilitation systems market size is…
KELOWNA, BC / ACCESSWIRE / October 16, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX; LEXXW) (the "Company" or "Lexaria"), a global…
WEST PLAINS, Mo., Oct. 16, 2024 /PRNewswire/ -- Ozarks Healthcare has announced a strategic partnership with Avo, (formerly known as…
MONROE TOWNSHIP, N.J., Oct. 16, 2024 /PRNewswire/ -- Bracco Diagnostics Inc., a U.S. subsidiary of Bracco Imaging S.p.A, one of…
LOS ANGELES, Oct. 16, 2024 /PRNewswire/ -- 70 million Americans suffer from gastrointestinal (GI) disorders, including conditions like Irritable Bowel…
American Heart Association Ventures invests in MDisruptLisa Suennen, Managing Partner of American Heart Association Ventures and longtime healthcare veteran, joins…